Pharmacological characterization of sigma binding sites in guinea pig brain membranes.

[1]  M. Pontecorvo,et al.  Ifenprodil potently interacts with [3H](+)-3-PPP-labeled sigma binding sites in guinea pig brain membranes. , 1990, European journal of pharmacology.

[2]  Y. Itzhak,et al.  Differential regulation of σ and PCP receptors after chronic administration of haloperidol and phencyclidine in mice , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  E. D. De Souza,et al.  Sigma-receptors in endocrine organs: identification, characterization, and autoradiographic localization in rat pituitary, adrenal, testis, and ovary. , 1989, Endocrinology.

[4]  E. Mackenzie,et al.  Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. , 1988, The Journal of pharmacology and experimental therapeutics.

[5]  G. F. Steinfels,et al.  Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)-pentazocine. , 1988, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[6]  J. Musacchio,et al.  High affinity dextromethorphan binding sites in guinea pig brain: further characterization and allosteric interactions. , 1988, The Journal of pharmacology and experimental therapeutics.

[7]  M. Pontecorvo,et al.  Dextromethorphan inhibits NMDA-induced convulsions. , 1988, European journal of pharmacology.

[8]  W. Bowen,et al.  σ Receptors negatively modulate agonist-stimulated phosphoinositide metabolism in rat brain , 1988 .

[9]  E. London,et al.  Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. , 1988, Science.

[10]  D. Prince,et al.  Dextromethorphan protects against cerebral infarction in a rat model of hypoxia-ischemia , 1988, Neuroscience Letters.

[11]  D. Choi,et al.  Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture , 1987, Neuroscience Letters.

[12]  T. Su,et al.  Guinea-pig vas deferens preparation may contain both receptors and phencyclidine receptors. , 1987, European journal of pharmacology.

[13]  M. Sonders,et al.  1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  F. Tortella,et al.  Dextromethorphan and carbetapentane: centrally acting non-opioid antitussive agents with novel anticonvulsant properties , 1986, Brain Research.

[15]  S. Snyder,et al.  Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. , 1986, The Journal of pharmacology and experimental therapeutics.

[16]  M. Williams,et al.  Radioligand binding to central phencyclidine recognition sites is dependent on excitatory amino acid receptor agonists. , 1986, European journal of pharmacology.

[17]  A. Maggi,et al.  Role of female gonadal hormones in the CNS: clinical and experimental aspects. , 1985, Life sciences.

[18]  R. Spealman,et al.  Stereoselective behavioral effects of N-allylnormetazocine in pigeons and squirrel monkeys. , 1985, The Journal of pharmacology and experimental therapeutics.

[19]  S. Tam,et al.  Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[20]  N. Khansari,et al.  Phencyclidine-induced immunodepression. , 1984, Science.

[21]  H. Shannon.  Phencyclidine-like discriminative stimuli of (+)- and (-)-N-allylnormetazocine in rats. , 1982, European journal of pharmacology.

[22]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[23]  W. Bowen,et al.  Characterization of [3H] (+)-pentazocine, a highly selective sigma ligand. , 1990, Progress in clinical and biological research.

[24]  S. Snyder,et al.  Receptor mechanisms in antipsychotic drug action: focus on sigma receptors. , 1989, The Journal of neuropsychiatry and clinical neurosciences.

[25]  J. Musacchio,et al.  Effects of dextromethorphan site ligands and allosteric modifiers on the binding of (+)-[3H]3-(-3-hydroxyphenyl)-N-(1-propyl)piperidine. , 1989, Molecular pharmacology.

[26]  F. J. White,et al.  Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies. , 1988, The Journal of pharmacology and experimental therapeutics.

[27]  Duncan P. Taylor,et al.  Potential antipsychotic BMY 14802 selectively binds to sigma sites , 1987 .

[28]  E. J. Simon,et al.  Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes. , 1985, Molecular pharmacology.

[29]  B. Weiss,et al.  Behavioral pharmacology : the current status , 1975 .